Targeting the Broadly Pathogenic Kynurenine Pathway

Nonfiction, Science & Nature, Science, Other Sciences, Molecular Biology, Biological Sciences, Biochemistry
Cover of the book Targeting the Broadly Pathogenic Kynurenine Pathway by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319118703
Publisher: Springer International Publishing Publication: November 18, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319118703
Publisher: Springer International Publishing
Publication: November 18, 2015
Imprint: Springer
Language: English

Tryptophan metabolism via kynurenine pathway plays a critical role in both health and a variety of human diseases. This book highlights the known associations between kynurenine pathway and various disease states, as well as examines the current status of drug development and clinical trials of compounds known to alter tryptophan metabolism. The research plays a critical role in molecular targeted therapies directed at altering the kynurenine pathway of tryptophan metabolism. The initial and rate-limiting step of tryptophan metabolism is mediated by one of two enzymes, tryptophan-2,3-dioxygenase (TDO; predominantly in the liver, but also in the brain) and indoleamine-2,3-dioxygenase (IDO; in a host of tissues in response to immune activation). Targeting the enzymes IDO and TDO, as well as other downstream effectors would therefore be likely to generate novel treatment options that would be helpful in a wide variety of clinical settings. This book provides a unique bridge between basic mechanistic understanding of the role of the kynurenine pathway with translational applications and clinical relevance. It will explore the indications that tryptophan metabolism is a potential biomarker of disease activity, can contribute to local and possibly systemic immune suppression in cancer, and is an attractive target for which a variety of inhibitors are readily available.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Tryptophan metabolism via kynurenine pathway plays a critical role in both health and a variety of human diseases. This book highlights the known associations between kynurenine pathway and various disease states, as well as examines the current status of drug development and clinical trials of compounds known to alter tryptophan metabolism. The research plays a critical role in molecular targeted therapies directed at altering the kynurenine pathway of tryptophan metabolism. The initial and rate-limiting step of tryptophan metabolism is mediated by one of two enzymes, tryptophan-2,3-dioxygenase (TDO; predominantly in the liver, but also in the brain) and indoleamine-2,3-dioxygenase (IDO; in a host of tissues in response to immune activation). Targeting the enzymes IDO and TDO, as well as other downstream effectors would therefore be likely to generate novel treatment options that would be helpful in a wide variety of clinical settings. This book provides a unique bridge between basic mechanistic understanding of the role of the kynurenine pathway with translational applications and clinical relevance. It will explore the indications that tryptophan metabolism is a potential biomarker of disease activity, can contribute to local and possibly systemic immune suppression in cancer, and is an attractive target for which a variety of inhibitors are readily available.

More books from Springer International Publishing

Cover of the book Post-Sustainability and Environmental Education by
Cover of the book Dynamics in Logistics by
Cover of the book Noncommunicable Diseases by
Cover of the book Computer Vision – ECCV 2018 by
Cover of the book Algorithmic Mathematics by
Cover of the book EU Asylum Policies by
Cover of the book Gastrointestinal Pharmacology by
Cover of the book Healthy Volunteers in Commercial Clinical Drug Trials by
Cover of the book Advanced Concepts for Intelligent Vision Systems by
Cover of the book Search for the Higgs Boson in the Vector Boson Fusion Channel at the ATLAS Detector by
Cover of the book Managing BRCA Mutation Carriers by
Cover of the book Logic, Rewriting, and Concurrency by
Cover of the book The European Dimension of Germany’s Energy Transition by
Cover of the book Productive Biofilms by
Cover of the book Islamic Finance by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy